AEVR and AMDF are hosting a 2-day event in DC promoting research funding and advocacy around macular degeneration. They have committed to purchasing 2 units ($5K/ea) and have requested we have 8 total devices available for the event. We estimate the total initial expense to be $12.5K, offset by the return of 6 headsets ($6,600) and their purchase revenue of $10K. This nets approximately $4K for the business, provides good media content, and opens new doors with AEVR, AMDF, and other attendees like NEI and Apellis.

UNLV's program allows for up to 3 engineering interns to join VisionAid per semester. Their $18/hr pay is fully reimbursed by UNLV. For the summer, our interns did great work on the web controller and our CaneIQ prototype. UNLV's delayed program start resulted in an outstanding invoice of $25,810 yet to be paid to VisionAid (expected payment by Oct 1). This capital float has stopped us from seeking new interns for the Fall semester ($3,600/intern float projected). Increased capital would allow us to add resources to the team to continue our growth.

With the final stages of initial development in place, we will soon be in a position to roll out a formal launch effort. This will ideally include marketing video content, advertising, direct outreach, and conference attendance. The stronger the rollout out, the better foothold we can secure inthe market.

We have approximately $10K in final development costs for our version 1 between the XR app and web controller. From there, having flexibility to continue to improve and implement user feedback will be crucial. This also includes the ability to retain grade A development talent.

For patients and their loved ones, the Eye Disease Simulator is a game-changer. It bridges the gap between medical jargon and patient comprehension, offering a clearer understanding of the patient's condition. It fosters empathy among loved ones by providing them an insight into what the patient is experiencing, hence cultivating a supportive environment for the patient.

Eye Disease Simulator serves as an immersive learning tool. It can offer students studying ophthalmology and related medical fields a unique opportunity to understand and explore various eye diseases in a controlled and detailed virtual environment. This hands-on experience significantly enhances the quality of learning, making complex concepts more accessible and engaging for students.

Leveraging its unique functionality, designers can place CADD models, virtual environments, and objects in the headset experience while simulating a visual impairment. This immersive understanding can identify design flaws early, lowering costs, and encouraging designs that accommodate diverse user needs. The Eye Disease Simulator positions designers not just as creators, but as empathetic innovators.

Eye Disease Simulator amplifies awareness initiatives and advocacy movements with its immersive, empathetic experiences. Legislators formulating health policies to community members participating in a charity 5K can gain first-hand insights into the difficulties of living with eye diseases. This powerful exposure not only elevates public understanding but also ignites a compelling wave of empathy, fostering enduring support for individuals navigating these conditions.

For pharmaceutical firms, it provides an unprecedented method to demonstrate the effectiveness of their treatments to doctors & patients visually, simulating the potential slowdown of diseases like Glaucoma and AMD. This tangible demonstration is a powerful tool for encouraging better patient adherence, leading to more consistent drug usage.

An effective early-stage intervention tool like the Eye Disease Simulator promotes preventative care. Better patient education and adherence reduces long-term health risks, thereby lowering associated costs. The simulator effectively bridges the gap between these sectors, aligning their interests in a way that ultimately benefits patients.